HQIVX | VIVIX | HQIVX / VIVIX | |
Total Expense Ratio | 0.65 | 0.04 | 1,625% |
Annual Report Gross Expense Ratio | 0.65 | 0.04 | 1,625% |
Fund Existence | 11 years | 27 years | - |
Gain YTD | 5.217 | 2.452 | 213% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.92B | 189B | 3% |
Annual Yield % from dividends | 2.07 | 2.29 | 91% |
Returns for 1 year | 4.00 | 8.01 | 50% |
Returns for 3 years | 7.22 | 32.19 | 22% |
Returns for 5 years | 34.90 | 72.56 | 48% |
Returns for 10 years | 29.48 | 103.54 | 28% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QIBGX | 22.18 | -0.22 | -0.98% |
Federated Hermes MDT Balanced IS | |||
CSRYX | 37.66 | -0.39 | -1.02% |
Columbia Select Large Cap Value Inst3 | |||
PGLEX | 18.59 | -0.21 | -1.12% |
Putnam Focused International Equity R6 | |||
ALMZX | 26.45 | -0.38 | -1.42% |
Alger MidCap Growth Institutional Z-2 | |||
TRMCX | 30.57 | -0.51 | -1.64% |
T. Rowe Price Mid-Cap Value |